| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Abscess, Intra-Abdominal | |||||
| Cholecystitis | |||||
| Wound Infections | |||||
| Peritonitis | |||||
| Appendicitis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Abdominal Abscess | |||||
| Acalculous Cholecystitis | |||||
| Communicable Diseases | |||||
| Infection | |||||
| Wound Infection | |||||
| 3 | More general conditions related to this trial | ||||
| Abscess | |||||
| Biliary Tract Diseases | |||||
| Cecal Diseases | |||||
| Digestive System Diseases | |||||
| Disorders of Environmental Origin | |||||
| Gallbladder Diseases | |||||
| Gastroenteritis | |||||
| Gastrointestinal Diseases | |||||
| Intestinal Diseases | |||||
| Peritoneal Diseases | |||||
| Suppuration | |||||
| Wounds and Injuries | |||||
| 4 | Interventions listed in this trial | ||||
| CP-75385-02 Cefoperazone/sulbactam | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Cefoperazone | |||||
| Sulbactam | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Pfizer | |||||
|
